Aeroturn LLC, a turnstile manufacturer that offers 100% U.S.A.-made turnstiles, announced that the company’s turnstiles were selected for deployment at multiple locations of a major Biopharma manufacturer in North America. Biopharmaceutical, also known as a biologic(al) medical product, or biologic, is any pharmaceutical drug product manufactured in, extracted from, or semi-synthesized from biological sources. Different from totally synthesized pharmaceuticals, they include vaccines, blood, blood components, allergenics, somatic cells, gene therapies, tissues, recombinant therapeutic protein, and living medicines used in cell therapy.

With the current global health pandemic, the Biopharma manufacturer needed to upgrade the security at its central U.S. location quickly and efficiently. With a heavy focus on research and development, the Biopharma company was looking for a turnstile solution that could operate without any downtime and secure its perimeter effectively.

With major security upgrades over the years, the turnstile decision was based on performance. After researching multiple vendors and receiving live product demonstrations, the physical security team chose Aeroturn. “Aeroturn won the initial project back in 2018 and all future installations based on superior reputation, performance specifications, durability, endurance, our 5-year warranty and zero maintenance mechanisms, and a 10 million passages guarantee,” states Michael Stoll, VP of technical sales & marketing at Aeroturn.

With a phased approach, Aeroturn won Phase I in September of 2018 and deployed four lanes of its enhanced X-Wing turnstiles with custom LED’s that matched the corporate colors at the Biopharma company’s North American headquarters.  Phase II consisted of an additional 11 lanes of X-Wing turnstiles that were deployed the following year at another North American campus. 

Aeroturn was selected once again in 2020 to complete Phase III with an additional eight lanes of turnstiles and the remaining to be deployed at the end of 2020 at the same campus. Each location came with its own set of customized floor conditions, side entry cabling and low-profile platforms when necessary, making this a customized turnstile solution. In addition, all work was performed off-hours and weekends to help minimize disruption at the facility at no additional cost to the Biopharma company.